Beijing Tong Ren Tang Chinese Medicine Company Limited

SEHK:3613 Stok Raporu

Piyasa değeri: HK$6.6b

Beijing Tong Ren Tang Chinese Medicine Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Beijing Tong Ren Tang Chinese Medicine yıllık ortalama 1.6% oranında kazançlarını artırırken, Pharmaceuticals sektöründe kazançlar growing at 5.7% annual. Gelirler growing yılda ortalama 3.8% oranında artmaktadır. Beijing Tong Ren Tang Chinese Medicine'in özkaynak karlılığı 13.4% ve net marjı 35.9%'dir.

Anahtar bilgiler

1.6%

Kazanç büyüme oranı

1.6%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi5.6%
Gelir büyüme oranı3.8%
Özkaynak getirisi13.4%
Net Marj35.9%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Sep 06
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Recent updates

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up

Oct 04
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up

Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Sep 06
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?

Sep 02
Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk

Feb 05
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk

Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Jan 03
Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Sep 28
A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today

Jul 12
Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today

Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?

Mar 29
Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?

Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28

Apr 28
Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28

Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28

Mar 25
Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28

Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?

Oct 27
Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?

Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 28
Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Mar 11
Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Feb 04
What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?

Jan 18
Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?

Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?

Dec 29
Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?

Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Dec 11
Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Nov 23
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Gelir ve Gider Dağılımı

Beijing Tong Ren Tang Chinese Medicine nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SEHK:3613 Gelir, gider ve kazançlar (HKD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 241,3774944480
31 Mar 241,4515174400
31 Dec 231,5255404310
30 Sep 231,7216194080
30 Jun 231,9186973840
31 Mar 231,8246723660
31 Dec 221,7316463480
30 Sep 221,6056013430
30 Jun 221,4785553370
31 Mar 221,5175823430
31 Dec 211,5566083490
30 Sep 211,5045953430
30 Jun 211,4525833370
31 Mar 211,3845633240
31 Dec 201,3155423110
30 Sep 201,2464833140
30 Jun 201,1784243170
31 Mar 201,3054903400
31 Dec 191,4335563640
30 Sep 191,5055943760
30 Jun 191,5776323870
31 Mar 191,5466013780
31 Dec 181,5145813810
30 Sep 181,4665523730
30 Jun 181,4025403400
31 Mar 181,3305163350
31 Dec 171,2664903140
30 Sep 171,2124693090
30 Jun 171,1664493010
31 Mar 171,1344442840
31 Dec 161,0844202720
30 Sep 161,0634312470
30 Jun 161,0284102370
31 Mar 161,0023802390
31 Dec 159703542320
30 Sep 159393372360
30 Jun 158813202260
31 Mar 158343042160
31 Dec 147612872010
30 Sep 147332861730
30 Jun 146992671670
31 Mar 146522491560
31 Dec 136142201570

Kaliteli Kazançlar: 3613 yüksek düzeyde nakit dışı kazança sahiptir.

Büyüyen Kar Marjı: 3613 'nin mevcut net kar marjları (35.9%) geçen yılın (36.4%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 3613 şirketinin kazancı son 5 yılda yılda 1.6% oranında arttı.

Büyüme Hızlandırma: 3613 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: 3613 geçtiğimiz yıl negatif kazanç büyümesine ( -29.1% ) sahipti ve bu da onu Pharmaceuticals sektör ortalamasıyla ( 9.4% ) karşılaştırmayı zorlaştırıyordu.


Özkaynak Getirisi

Yüksek ROE: 3613 'nin Özsermaye Getirisi ( 13.4% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin